[Malaria chemoprophylaxis]

Area of Science:

• Tropical medicine
• Infectious disease epidemiology

Background:

• Malaria prevention traditionally relies on chemoprophylaxis, balancing side effect risks against infection risks.
• Current malaria prevention guidelines are based on limited data, including descriptive studies and case reports, due to a lack of prospective comparative trials.
• There is insufficient data on malaria infection risk in travelers, making national statistics on imported cases less useful without knowing the total number of at-risk travelers.

Purpose of the Study:

• To evaluate the comparative side effect profiles of different malaria chemoprophylaxis drugs.
• To address the lack of data on malaria infection risk among travelers.
• To inform evidence-based recommendations for malaria prevention in travelers.

Main Methods:

• A single prospective, double-blind study compared side effects of mefloquine, atovaquone/proguanil, doxycycline, and chloroquine/proguanil.
• Risk estimation for travelers is extrapolated from data on malaria in indigenous populations, assuming a lower risk for travelers.
• Drug registration data (e.g., duration limits for atovaquone/proguanil) and contraindications (e.g., pregnancy, infant weight) were considered.

Main Results:

• Only one prospective, double-blind study has compared the side effects of key malaria chemoprophylaxis drugs.
• Data on the actual risk of malaria infection in travelers is scarce.
• Atovaquone/proguanil has duration restrictions in Europe but not in the US; prophylaxis is not recommended for pregnant women in the first trimester or infants under 11kg traveling to tropical Africa.

Conclusions:

• The current understanding of malaria chemoprophylaxis efficacy and safety in travelers is limited by data scarcity.
• Balancing the risks and benefits of chemoprophylaxis remains a challenge due to incomplete evidence.
• Specific populations, including pregnant women and young infants, have limited or no effective chemoprophylaxis options for travel to malaria-endemic regions.